Correlation Between ATyr Pharma and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Intellia Therapeutics, you can compare the effects of market volatilities on ATyr Pharma and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Intellia Therapeutics.
Diversification Opportunities for ATyr Pharma and Intellia Therapeutics
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between ATyr and Intellia is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between ATyr Pharma and Intellia Therapeutics
Given the investment horizon of 90 days ATyr Pharma is expected to under-perform the Intellia Therapeutics. In addition to that, ATyr Pharma is 2.51 times more volatile than Intellia Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.06 per unit of volatility. If you would invest 3,084 in Intellia Therapeutics on August 27, 2024 and sell it today you would lose (1,654) from holding Intellia Therapeutics or give up 53.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 53.23% |
| Values | Daily Returns |
ATyr Pharma vs. Intellia Therapeutics
Performance |
| Timeline |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Intellia Therapeutics |
ATyr Pharma and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATyr Pharma and Intellia Therapeutics
The main advantage of trading using opposite ATyr Pharma and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |